Back to Search Start Over

Preparation and characterization of directly compactible layer-by-layer nanocoated cellulose

Authors :
Melgardt M. de Villiers
Schalk J. Strydom
Daniel P. Otto
Wilna Liebenberg
Yuri Lvov
10196226 - Liebenberg, Wilna
Source :
International Journal of Pharmaceutics. 404:57-65
Publication Year :
2011
Publisher :
Elsevier BV, 2011.

Abstract

Microcrystalline cellulose is a commonly used direct compression tablet diluent and binder. It is derived from purified α-cellulose in an environmentally unfriendly process that involves mineral acid catalysed hydrolysis. In this study Kraft softwood fibers was nanocoated using a layer-by-layer self-assembling process. Powder flow and compactibility results showed that the application of nano-thin polymer layers on the fibers turned non-flowing, non-compacting cellulose into powders that can be used in the direct compression of tablets. The powder flow properties and tableting indices of compacts compressed from these nanocoated microfibers were similar or better than that of directly compactible microcrystalline cellulose powders. Cellulose microfibers coated with four PSS/PVP bilayers had the best compaction properties while still producing tablets that were able to absorb water and disintegrate and did not retard the dissolution of a model drug acetaminophen. The advantages of nanocoating rather than traditional pharmaceutical coating are that it add less than 1% to the weight of the fibers and allows control of the molecular properties of the surface and the thickness of the coat to within a few nanometers. This process is potentially friendlier to the environment because of the type and quantity of materials used. Also, it does not involve acid-catalyzed hydrolysis and neutralization of depolymerized cellulose. http://dx.doi.org/10.1016/j.ijpharm.2010.10.056

Details

ISSN :
03785173
Volume :
404
Database :
OpenAIRE
Journal :
International Journal of Pharmaceutics
Accession number :
edsair.doi.dedup.....d1b9c77a7a41fc444be4025f991fc8c2
Full Text :
https://doi.org/10.1016/j.ijpharm.2010.10.056